HLB Panagene Co., Ltd. (KOSDAQ:046210)
South Korea · Delayed Price · Currency is KRW 2,135.00
-185.00 (-7.97%)
At close: Feb 26, 2026
HLB Panagene Market Cap
HLB Panagene has a market cap or net worth of 90.85 billion as of February 27, 2026. Its market cap has decreased by -28.57% in one year.
Market Cap
90.85B
Enterprise Value
64.94B
Revenue
14.29B
Ranking
n/a
PE Ratio
54.39
Stock Price
2,135.00
Market Cap Chart
Since August 29, 2001, HLB Panagene's market cap has increased from 17.29B to 90.85B, an increase of 425.45%. That is a compound annual growth rate of 7.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 90.85B | 15.09% |
| Dec 30, 2025 | 78.94B | -34.15% |
| Dec 30, 2024 | 119.87B | -29.22% |
| Dec 28, 2023 | 169.35B | 24.28% |
| Dec 29, 2022 | 136.26B | 11.73% |
| Dec 30, 2021 | 121.96B | -11.85% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| 3billion | 458.95B |
| Dx & Vx | 453.76B |
| Cytogen | 126.42B |
| GENINUS | 117.06B |
| Green Cross Medical Science | 82.84B |
| Protia | 67.09B |
| Seoulin Bioscience | 58.08B |
| GeneMatrix | 47.01B |